Cargando…

Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States

BACKGROUND: Hypoglycemia is a major limiting factor in achieving glycemic control in persons with diabetes. In some instances, recovery from a severe hypoglycemia event may require health care resource utilization (HCRU), including the use of emergency medical services (EMS), visits to the emergency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajpai, Sanjay, Wong-Jacobson, Siew, Liu, Dongju, Mitchell, Beth, Haynes, Ginger, Syring, Kristen, Ali, Ayad K, Chinthammit, Chanadda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2021
Materias:	Research Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391039/ https://www.ncbi.nlm.nih.gov/pubmed/33645242 http://dx.doi.org/10.18553/jmcp.2021.27.3.385

Ejemplares similares

FRI639 Effect Of Early Initiation Of GLP-1 RAs On Weight Reduction Among People With Type 2 Diabetes
por: Chinthammit, Chanadda, et al.
Publicado: (2023)

Type 2 diabetes pharmacotherapy trends in high‐risk subgroups
por: Bae, Jay, et al.
Publicado: (2022)

An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations
por: Bae, Jay P., et al.
Publicado: (2022)

The multinational Conversations and Reactions Around Severe Hypoglycemia (CRASH) study: Impact of health care provider communications and recommendations on people with diabetes
por: Snoek, Frank J., et al.
Publicado: (2022)

Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications
por: Axon, David R, et al.
Publicado: (2020)

Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample
por: Campbell, Patrick J., et al.
Publicado: (2021)

Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia
por: Giménez, Marga, et al.
Publicado: (2023)

The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database
por: Eby, Elizabeth L., et al.
Publicado: (2020)

Evaluation of a guided continuous quality improvement program in community pharmacies
por: Chinthammit, Chanadda, et al.
Publicado: (2017)

Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
por: Snoek, Frank J., et al.
Publicado: (2022)

A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs
por: Yi, Yingping, et al.
Publicado: (2018)

Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization
por: Dalal, Mehul R., et al.
Publicado: (2017)

Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
por: Osumili, Beatrice, et al.
Publicado: (2022)

Associations of Renin‐Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort Study
por: Campbell, Patrick J., et al.
Publicado: (2020)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study
por: Wu, Jianmin, et al.
Publicado: (2021)

Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia
por: Bajpai, Sanjay K, et al.
Publicado: (2022)

Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study
por: Chinthammit, Chanadda, et al.
Publicado: (2021)

Importance of Insulin Immunoassays in the Diagnosis of Factitious Hypoglycemia
por: Nalbantoğlu Elmas, Özlem, et al.
Publicado: (2014)

The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017)

Paliperidone Induced Hypoglycemia by Increasing Insulin Secretion
por: Omi, Tsubasa, et al.
Publicado: (2016)

Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes
por: Groener, Jan Benedikt, et al.
Publicado: (2019)

Effect of Naloxon on Counter Insulin Hormone Secretion in Insulin-Induced Hypoglycemia
por: Ju, Yeong Shil, et al.
Publicado: (1987)

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
por: Su, Chih-Ting, et al.
Publicado: (2016)

Current Procedural Terminology Codes for Medication Therapy Management in Administrative Data
por: Axon, David R., et al.
Publicado: (2020)

Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
por: Almigbal, Turky H
Publicado: (2021)

Rare Cause of Recurrent Hypoglycemia: Insulin Autoimmune Syndrome
por: Tinmanee, Rungsima, et al.
Publicado: (2017)

Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017)

SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019)

Insulin autoimmune syndrome: A rare cause of hypoglycemia
por: Maheshwari, Tejas M., et al.
Publicado: (2020)

The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
por: Crnobrnja, Ljiljana, et al.
Publicado: (2020)

Persistent Hypoglycemia Induced by Long-acting Insulin Degludec
por: Katakura, Yukino, et al.
Publicado: (2021)

A Case of Autoimmune Hypoglycemia (Insulin Autoimmune Syndrome)
por: Mon Myint, Myat Su, et al.
Publicado: (2021)

Is biochemical hypoglycemia necessary during an insulin tolerance test?
por: Simsek, Yasin, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Kim, Ashley, et al.
Publicado: (2021)

Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region
por: Chinthammit, Chanadda, et al.
Publicado: (2020)

Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder
por: Ta, Jamie T, et al.
Publicado: (2021)

Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis
por: Lucidi, Paola, et al.
Publicado: (2010)

Insulin Detemir Versus Insulin Glargine in the Hospital: Do Hypoglycemia Rates Differ?
por: Crisher, Michelle A., et al.
Publicado: (2019)

Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population
por: Gómez, Ana M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3e7aqs8nthcr79aljfep941541